Amended Current Report Filing (8-k/a)
August 02 2017 - 5:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K/A
Amendment No. 1
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2017
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-14057
|
|
61-1323993
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
680 South Fourth Street
Louisville, Kentucky
(Address of principal executive offices)
40202
(Zip Code)
Registrants telephone number, including area code: (502)
596-7300
Not Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
☐
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§ 240.12b-2
of
this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
As previously reported on a Form
8-K
filed on May 25, 2017, at the 2017 annual meeting of shareholders of Kindred Healthcare, Inc. (Kindred), Kindreds shareholders voted to approve an annual advisory vote with respect to
compensation of Kindreds named executive officers.
Pursuant to paragraph (d) of Item 5.07, this amendment to the
previously-filed Form
8-K
is being filed to report that, on August 2, 2017, the Kindred Board of Directors adopted the shareholder recommendation to have an annual advisory vote with respect to
compensation of Kindreds named executive officers. The next required advisory vote on the frequency of shareholder votes on executive compensation will occur at Kindreds 2023 Annual Meeting of Shareholders.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
KINDRED HEALTHCARE, INC.
|
|
|
|
|
Date: August 2, 2017
|
|
|
|
By:
|
|
/s/ Joseph L. Landenwich
|
|
|
|
|
|
|
Joseph L. Landenwich
|
|
|
|
|
|
|
General Counsel and Corporate Secretary
|
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kindred Healthcare (NYSE:KND)
Historical Stock Chart
From Apr 2023 to Apr 2024